1. Home
  2. FNKO vs PROK Comparison

FNKO vs PROK Comparison

Compare FNKO & PROK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Funko Inc.

FNKO

Funko Inc.

N/A

Current Price

$6.45

Market Cap

382.5M

ML Signal

N/A

Logo ProKidney Corp.

PROK

ProKidney Corp.

N/A

Current Price

$1.09

Market Cap

359.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FNKO
PROK
Founded
2017
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Recreational Games/Products/Toys
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
382.5M
359.4M
IPO Year
2017
2021

Fundamental Metrics

Financial Performance
Metric
FNKO
PROK
Price
$6.45
$1.09
Analyst Decision
Buy
Buy
Analyst Count
2
6
Target Price
★ $7.25
$6.50
AVG Volume (30 Days)
941.2K
★ 1.1M
Earning Date
11-05-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
★ N/A
N/A
Revenue
★ $908,209,000.00
$893,000.00
Revenue This Year
$2.98
N/A
Revenue Next Year
$8.18
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ 1075.00
52 Week Low
$2.72
$1.29
52 Week High
$7.35
$2.95

Technical Indicators

Market Signals
Indicator
FNKO
PROK
Relative Strength Index (RSI) 52.00 27.33
Support Level $5.13 N/A
Resistance Level $6.58 $2.01
Average True Range (ATR) 0.28 0.14
MACD -0.05 -0.03
Stochastic Oscillator 31.93 18.46

Price Performance

Historical Comparison
FNKO
PROK

About FNKO Funko Inc.

Funko Inc is an USA based pop culture consumer products company. It creates whimsical, fun, and different products that enable the customer to express their affinity for their favorite through the movie, TV show, video game, musician, or sports team. The company's current products are principally figures, fashion accessories, apparel, plush products, accessories, homewares, and NFTs. The company sells its products through a diverse network of retail customers across multiple retail channels, including specialty retailers, mass-market retailers, and e-commerce sites. The company generates the majority of its revenue from the core collectibles products.

About PROK ProKidney Corp.

ProKidney Corp is a clinical-stage biotechnology company pioneering the development of a first-in-class, autologous cell therapy that is intended to preserve kidney function in patients with advance chronic kidney disease (CKD) and diabetes. Its product candidate, REACT (Renal Autologous Cell Therapy), is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.

Share on Social Networks: